CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Long, thin, well-defined muscle fibers (top left) are in shambles after prolonged inflammation (top right), but maintain their structure (bottom left) and strength (bottom right) when exercised during the inflammation.

January 25, 2021 | Pratt School of Engineering

Exercising Muscle Combats Chronic Inflammation On Its Own

Exercising lab-grown human muscle autonomously blocks the damaging effects of interferon gamma

Tissue velocity field and its divergence

January 7, 2021 | Duke Precision Genomics Collaboratory

How does a fish grow back scales?

How does a fish grow back scales it has lost to be the right size? Why don’t they just keep growing? The secret lies in waves of Erk activity.

Clair Engstrom

January 4, 2021 | Duke Research Blog

Claire Engstrom, a Student Researcher Working to Treat Duchenne’s Muscular Dystrophy by Optimizing CRISPR-cas9

Claire first got involved with on-campus research through her pre-orientation program, PSearch.